The markedly increased risk of diabetes
and cardiovascular disease (CVD)
underlines the importance of this
metabolic syndrome congress. Discover
pioneering research and explore the
latest issues from gut hormones in
obesity; GLP-1 mimetics and DPP-4
inhibitors in early diabetes and the
metabolic syndrome; the role of the
GLP-1 axis in prevention, cardiovascular
health and cognition; and lessons from
bariatric surgery and interventional
diabetology.
Learn from world leaders, network with
fellow specialist, and enjoy the
beautiful, historic setting of Vienna.
